cis- and trans-2-Mercaptocyclobutylamines. Synthesis and antilipolytic properties in vitro.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D002082:Butylamines / Q000138:chemical synthesis* / Q000494:pharmacology; D002087:Butyrates / Q000037:antagonists & inhibitors; D000242:Cyclic AMP / Q000037:antagonists & inhibitors; D003503:Cyclobutanes / Q000138:chemical synthesis / Q000494:pharmacology; D003516:Cycloparaffins / Q000138:chemical synthesis*; D003543:Cysteamine / Q000138:chemical synthesis / Q000494:pharmacology; D003864:Depression, Chemical; D004336:Drug Antagonism; D005990:Glycerol / Q000378:metabolism; D008053:Lipid Mobilization / Q000187:drug effects*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D051381:Rats; D013237:Stereoisomerism; D013329:Structure-Activity Relationship; D013438:Sulfhydryl Compounds / Q000138:chemical synthesis* / Q000494:pharmacology; D013806:Theophylline / Q000037:antagonists & inhibitors
D002082:Butylamines; D002087:Butyrates; D003503:Cyclobutanes; D003516:Cycloparaffins; D013438:Sulfhydryl Compounds; D003543:Cysteamine; D013806:Theophylline; D000242:Cyclic AMP; D005990:Glycerol; D009638:Norepinephrine